WELLS FARGO & COMPANY/MN - BIOLINERX LTD ownership

BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 25 filers reported holding BIOLINERX LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of BIOLINERX LTD
ValueSharesWeighting
Q2 2019$15,000
-11.8%
40,5300.0%0.00%
Q1 2019$17,000
-5.6%
40,5300.0%0.00%
Q4 2018$18,000
+1700.0%
40,530
+7547.2%
0.00%
Q3 2018$1,0005300.0%0.00%
Q2 2018$0
-100.0%
530
-73.5%
0.00%
Q1 2018$2,000
+100.0%
2,000
+100.0%
0.00%
Q3 2017$1,0000.0%1,0000.0%0.00%
Q2 2017$1,0000.0%1,0000.0%0.00%
Q1 2017$1,0000.0%1,0000.0%0.00%
Q4 2016$1,0000.0%1,0000.0%0.00%
Q3 2016$1,0000.0%1,0000.0%0.00%
Q2 2016$1,0000.0%1,0000.0%0.00%
Q1 2016$1,0000.0%1,0000.0%0.00%
Q4 2015$1,000
-50.0%
1,0000.0%0.00%
Q3 2015$2,000
-33.3%
1,0000.0%0.00%
Q2 2015$3,000
-25.0%
1,000
-50.0%
0.00%
Q1 2015$4,000
+100.0%
2,000
+100.0%
0.00%
Q4 2014$2,0000.0%1,0000.0%0.00%
Q3 2014$2,0000.0%1,0000.0%0.00%
Q2 2014$2,0000.0%1,0000.0%0.00%
Q1 2014$2,000
-33.3%
1,0000.0%0.00%
Q4 2013$3,000
+50.0%
1,0000.0%0.00%
Q3 2013$2,0000.0%1,0000.0%0.00%
Q2 2013$2,0001,0000.00%
Other shareholders
BIOLINERX LTD shareholders Q1 2015
NameSharesValueWeighting ↓
BVF INC/IL 1,501,000$2,432,0000.47%
Senvest Management, LLC 2,278,995$3,692,0000.26%
Opaleye Management Inc. 250,000$405,0000.20%
SABBY MANAGEMENT, LLC 928,758$1,505,0000.05%
Benchmark Capital Advisors 40,000$65,0000.04%
Orbimed Advisors 1,135,000$1,839,0000.02%
NEXT Financial Group, Inc 28,500$46,0000.02%
Cutter & CO Brokerage, Inc. 10,000$16,0000.01%
Tower Research Capital LLC (TRC) 110$00.00%
Renaissance Technologies 26,878$44,0000.00%
View complete list of BIOLINERX LTD shareholders